Anbio Biotechnology
Last updated September 27, 2026
Organization details
- Legal name
- Anbio Biotechnology
- Ownership
- Public
- Status
- Active
- SIC code
- 2835 — In Vitro & In Vivo Diagnostic Substances
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- Frankfurt AM Main
- Headquarters country
- Germany
- Fiscal year end
- December
- Ticker symbol
- NNNN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001982708
Board of directors
-
Cany Xu · DirectorSince 2026
-
David H. Hsu · DirectorSince 2026
-
Michael W.c Zhang · DirectorSince 2026
-
Nancy Hartzler · DirectorSince 2026
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.